Vyripharm Enterprises has a total of 28 patents globally, out of which 8 have been granted. Of these 28 patents, more than 82% patents are active. United States of America is where Vyripharm Enterprises has filed the maximum number of patents, followed by Europe and China. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Vyripharm Enterprises.
Vyripharm Enterprises was founded in the year 2014. The Company is a biotechnology research firm that offers personalized medicine and drug development services.
Do read about some of the most popular patents of Vyripharm Enterprises which have been covered by us in this article and also you can find Vyripharm Enterprises patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Vyripharm Enterprises patent portfolio.
How many patents does Vyripharm Enterprises have?
Vyripharm Enterprises has a total of 28 patents globally. These patents belong to 2 unique patent families. Out of 28 patents, 23 patents are active.
How Many Patents did Vyripharm Enterprises File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Vyripharm Enterprises Applications Filed | Vyripharm Enterprises Patents Granted |
| 2023 | – | 4 |
| 2022 | – | 2 |
| 2021 | 3 | – |
| 2020 | 13 | – |
| 2019 | 2 | 1 |
| 2018 | 8 | – |
| 2017 | 1 | 1 |
| 2014 | 1 | – |
How many Vyripharm Enterprises patents are Alive/Dead?
How Many Patents did Vyripharm Enterprises File in Different Countries?
Countries in which Vyripharm Enterprises Filed Patents
| Country | Patents |
| United States Of America | 4 |
| South Africa | 3 |
| China | 2 |
| Mexico | 2 |
| Korea (South) | 2 |
| Europe | 2 |
| Peru | 2 |
| Canada | 2 |
| India | 2 |
| Australia | 2 |
| Israel | 2 |
| Hong Kong (S.A.R.) | 1 |
| Eurasia | 1 |
Where are Research Centres of Vyripharm Enterprises Patents Located?
The Research Centre for all the Vyripharm Enterprises patents is the United States of America.
Best Vyripharm Enterprises Patents
US9632069B2 is the most popular patent in the Vyripharm Enterprises portfolio. It has received 16 citations so far from companies like Enigami Systems, Inc., Radient Technologies Innovations Inc. and Poshmark, Inc.
What Percentage of Vyripharm Enterprises US Patent Applications were Granted?
Vyripharm Enterprises (Excluding its subsidiaries) has filed 4 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 3 have been granted leading to a grant rate of 100.0%.
Below are the key stats of Vyripharm Enterprises patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Vyripharm Enterprises?
| Law Firm | Total Applications | Success Rate |
| Houston Office Of | 4 | 100.00% |
List of Vyripharm Enterprises Patents
| Vyripharm Enterprises Patents | Title |
| US11378564B2 | Systems And Methods For Integrated And Comprehensive Management Of Cannabis Products |
| US10222361B2 | Integrated Systems And Methods Of Evaluating Cannabis And Cannabinoid Products For Public Safety, Quality Control And Quality Assurance Purposes |
| US9632069B2 | Integrated Systems And Methods Of Evaluating Cannabis And Cannabinoid Products For Public Safety, Quality Control And Quality Assurance Purposes |
| EP3706065A1 | Systems And Methods For Integrated And Comprehensive Management Of Cannabis Products |
| CN111653332A | Cannabis Product Integrated Comprehensive Management System And Method |
| CN111065391A | Compositions Containing Cannabinoid Analog Conjugates And Methods Of Use |
| CA3068720A1 | Compositions Containing Cannabinoid Analog Conjugates And Methods Of Use |
| CA3070538A1 | Compositions Containing Cannabinoid Analog Conjugates And Methods Of Use |
| AU2018302155B2 | Compositions Containing Cannabinoid Analog Conjugates And Methods Of Use |
| AU2020200390A1 | Systems And Methods For Integrated And Comprehensive Management Of Cannabis Products |
| HK40037285A | Systems And Methods For Integrated And Comprehensive Management Of Cannabis Products |
| IN202017003522A | Compositions Containing Cannabinoid Analog Conjugates And Methods Of Use |
| MX403065B | Compositions Containing Analogue Conjugates Of Cannabinoids And Methods Of Use |
| ZA202001552B | Systems And Methods For Integrated And Comprehensive Management Of Cannabis Products |
| ZA202106450B | Systems And Methods For Integrated And Comprehensive Management Of Cannabis Products |
| ZA202106452B | Systems And Methods For Integrated And Comprehensive Management Of Cannabis Products |
| MX2020000865A | Systems And Methods For Integrated And Comprehensive Management Of Cannabis Products. |
| KR1020200106449A | Systems And Methods For Integrated And Comprehensive Management Of Cannabis Products |
| PE0008662020A1 | Compositions Containing Cannabinoid Analog Conjugates And Methods Of Use |
| EA202090116A1 | Compositions Containing Cannabinoid Analogue Conjugates And Methods Of Use |
| IL272060A | Compositions Containing Cannabinoid Analog Conjugates And Methods Of Use |
| IL271681A | Systems And Methods For Integrated And Comprehensive Management Of Cannabis Products |
| US20210080441A1 | Compositions Containing Cannabinoid Analog Conjugates And Methods Of Use |
| EP3654971A4 | Compositions Containing Cannabinoid Analog Conjugates And Methods Of Use |
| WO2019018536A1 | Compositions Containing Cannabinoid Analog Conjugates And Methods Of Use |
| IN202014003523A | “Systems And Methods For Integrated And Comprehensive Management Of Cannabis Products” |
| KR1020200031663A | Compositions Comprising Cannabinoid Analog Conjugates And Methods Of Use |
What are Vyripharm Enterprises key innovation segments?
What Technologies are Covered by Vyripharm Enterprises?
The chart below distributes patents filed by Vyripharm Enterprises